Pediatric heart failure: Current approach and treatment
- PMID: 40697906
- PMCID: PMC12281176
- DOI: 10.1016/j.jhlto.2025.100331
Pediatric heart failure: Current approach and treatment
Abstract
Pediatric heart failure (HF) is a heterogenous disease process. While the incidence is low compared to adults, resource utilization and in hospital mortality is higher. We aim to review the current approaches and treatment strategies for pediatric HF and discuss ongoing efforts to improve outcomes for this patient population. Pediatric HF is a diverse disease entity with variable pathophysiologic processes and symptoms. This review will focus on myocardial failure related to intrinsic cardiomyocyte, or cardiac muscle cell, dysfunction. While myocardial failure is a shared pathway in adult and pediatric HF, unique disease mechanisms are observed in pediatric patients, providing potential explanations for why existing HF treatment regimens are more effective in adults than children. Diagnosis and serial assessment of pediatric HF is achieved by employing multimodality imaging techniques, laboratory evaluation, and cardiac catheterization, as well as sleep and exercise studies. Pharmacologic therapies are largely based on adult guideline directed medical therapy, although supportive evidence is lacking in pediatric HF. Novel therapies are being developed that have potential for efficacy based on the current understanding of pediatric specific HF pathophysiology. Medical therapy for HF is often complemented by non-pharmacologic therapies, and in cases of end stage HF, patients may require ventricular assist devices or heart transplantation. The current approaches and treatments of pediatric HF face unique challenges; however, there is reason for an optimistic future. Improved outcomes can be achieved by utilizing emerging therapies and technologies, increasing collaboration, and through a dedication to delivering equitable care.
Keywords: ACE inhibitors; Beta-blockers; Cardiomyopathy; Children; Heart failure.
© 2025 International Society for Heart and Lung Transplantation.
Conflict of interest statement
The authors declare the following financial interests/personal relationships, which may be considered as potential competing interests: Shelley D. Miyamoto reports a relationship with Bayer Corporation that includes: board membership. Shelley D. Miyamoto reports a relationship with Secretome Therapeutics that includes: board membership. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement.PM R. 2025 Jun;17(6):684-708. doi: 10.1002/pmrj.13397. Epub 2025 Apr 22. PM R. 2025. PMID: 40261198
-
Systemic Inflammatory Response Syndrome.2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613449 Free Books & Documents.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714
References
-
- Hsu D.T., Pearson G.D. Heart failure in children: part I: history, etiology, and pathophysiology. Circ Heart Fail. 2009;2:63–70. - PubMed
-
- Heidenreich P.A., et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895–e1032. - PubMed
-
- Katz A.M. The "modern" view of heart failure: How did we get here? Circ Heart Fail. 2008;1:63–71. - PubMed
-
- Amdani S., et al. Burden of pediatric heart failure in the United States. J Am Coll Cardiol. 2022;79:1917–1928. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous